Fluid ORiented Therapy for yoUNg Asa 1patients

Institute of Hospitalization and Scientific Care (IRCCS)

Status: Completed

Conditions: Hemodynamics

Treatments: Device: FloTrac

Study type: Interventional

Funder types: Other

Identifiers

NCT03090399

FORTUNA study

Details and patient eligibility

About

In this retrospective analysis investigators will study the effects of using a minimally invasive hemodynamic monitoring (FloTrac-Edwards) on postoperative outcomes. Participants will compare a control group to a case group; in both groups ASA 1 patients suffering from advanced ovarian cancer underwent radical cytoreductive surgery. In case group hemodynamic was managed by using the FloTrac system; in the control group a standard hemodynamic monitoring was used.

Enrollment: 60 patients

Sex: Female

Ages: 18 to 65 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• ASA 1

Exclusion criteria

• cardiac diseases
• pulmonary diseases
• renal diseases
• metabolic disorders

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

60 participants in 2 patient groups

control group

No Intervention group

Description:

patients in which standard fluid administration was applied

case group

Active Comparator group

Description:

patients in which fluids were administered according to FloTrac parameters

Treatment:

Device: FloTrac